Next Article in Journal
Ilaprazole and Clopidogrel Resistance in Acute Stroke Patients
Previous Article in Journal
Increased Abundances of CD16+ Non-Classical Monocytes Accompany with Elevated Monocytic PD-L1 and CD4+ T Cell Disturbances in Oropharyngeal Cancer
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Chronic Rhinosinusitis, S. aureus Biofilm and Secreted Products, Inflammatory Responses, and Disease Severity

by
Gohar Shaghayegh
1,2,3,
Clare Cooksley
1,2,3,
Mahnaz Ramezanpour
1,2,3,
Peter-John Wormald
1,2,3,
Alkis James Psaltis
1,2,3 and
Sarah Vreugde
1,2,3,*
1
Adelaide Medical School, Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide 5000, Australia
2
Department of Surgery-Otolaryngology-Head and Neck Surgery, University of Adelaide, Adelaide 5011, Australia
3
Central Adelaide Local Health Network, The Queen Elizabeth Hospital, The Basil Hetzel Institute for Translational Health Research, Woodville South 5011, Australia
*
Author to whom correspondence should be addressed.
Biomedicines 2022, 10(6), 1362; https://doi.org/10.3390/biomedicines10061362
Submission received: 10 May 2022 / Revised: 6 June 2022 / Accepted: 6 June 2022 / Published: 9 June 2022
(This article belongs to the Section Microbiology in Human Health and Disease)

Abstract

Chronic rhinosinusitis (CRS) is a persistent inflammation of the nasal cavity and paranasal sinuses associated with tissue remodelling, dysfunction of the sinuses’ natural defence mechanisms, and induction of different inflammatory clusters. The etiopathogenesis of CRS remains elusive, and both environmental factors, such as bacterial biofilms and the host’s general condition, are thought to play a role. Bacterial biofilms have significant clinical relevance due to their potential to cause resistance to antimicrobial therapy and host defenses. Despite substantial medical advances, some CRS patients suffer from recalcitrant disease that is unresponsive to medical and surgical treatments. Those patients often have nasal polyps with tissue eosinophilia, S. aureus-dominant mucosal biofilm, comorbid asthma, and a severely compromised quality of life. This review aims to summarise the contemporary knowledge of inflammatory cells/pathways in CRS, the role of bacterial biofilm, and their impact on the severity of the disease. Here, an emphasis is placed on S. aureus biofilm and its secreted products. A better understanding of these factors might offer important diagnostic and therapeutic perceptions for recalcitrant disease.
Keywords: chronic rhinosinusitis; S. aureus biofilm/virulence factor; inflammatory cells/endotypes chronic rhinosinusitis; S. aureus biofilm/virulence factor; inflammatory cells/endotypes

Share and Cite

MDPI and ACS Style

Shaghayegh, G.; Cooksley, C.; Ramezanpour, M.; Wormald, P.-J.; Psaltis, A.J.; Vreugde, S. Chronic Rhinosinusitis, S. aureus Biofilm and Secreted Products, Inflammatory Responses, and Disease Severity. Biomedicines 2022, 10, 1362. https://doi.org/10.3390/biomedicines10061362

AMA Style

Shaghayegh G, Cooksley C, Ramezanpour M, Wormald P-J, Psaltis AJ, Vreugde S. Chronic Rhinosinusitis, S. aureus Biofilm and Secreted Products, Inflammatory Responses, and Disease Severity. Biomedicines. 2022; 10(6):1362. https://doi.org/10.3390/biomedicines10061362

Chicago/Turabian Style

Shaghayegh, Gohar, Clare Cooksley, Mahnaz Ramezanpour, Peter-John Wormald, Alkis James Psaltis, and Sarah Vreugde. 2022. "Chronic Rhinosinusitis, S. aureus Biofilm and Secreted Products, Inflammatory Responses, and Disease Severity" Biomedicines 10, no. 6: 1362. https://doi.org/10.3390/biomedicines10061362

APA Style

Shaghayegh, G., Cooksley, C., Ramezanpour, M., Wormald, P.-J., Psaltis, A. J., & Vreugde, S. (2022). Chronic Rhinosinusitis, S. aureus Biofilm and Secreted Products, Inflammatory Responses, and Disease Severity. Biomedicines, 10(6), 1362. https://doi.org/10.3390/biomedicines10061362

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop